Reported Nov 25, 2015 · Terminated

iCup Drug Screen Cup, Item No. I-DXA-187-016, I-DXA-167-013; iCup DX 10 Panel w/Adulterant, Item No. I-DXA-1107-142;…

Ameditech Inc.

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: Ameditech Inc · 9940 Mesa Rim Rd · San Diego, CA · 92121-2910

Is this the product you have?

7 of 7 products

Products covered by this recall
Model / numberProduct as published
I-DXA-187-016iCup Drug Screen Cup, , I-DXA-167-013
I-DXA-1107-142iCup DX 10 Panel w/Adulterant
I-DXA-1117-131iCup DX 11 Panel w/Adulterant
I-DXA-1127-023iCup DX 12 Panel w/Adulterant
I-DXA-167-013iCup DX 6 Panel w/Adulterant
I-DXA-187-016iCup DX 8 Panel w/Adulterant
I-DXA-1127-023iCup DX Drug Screen, These Drugs of Abuse Tests are one-step immunoassays for the qualitative detection of multiple drugs and drug metabolites in human urine. The configurations of these Drugs of Abuse Tests consist of a combination of drug strips, including Benzodiazepine (BZO). They are used to obtain a visual, qualitative result and are intended for professional and point of care use. ¿¿¿
Lot codes and dates
    • 141210
    • 141425
    • 141561
    • 141870
    • 141994
    • 142126
    • 143608
    • 144152
    • 144218
    • 145067
    • 150105
    • 150167
    • 151215
    • 150976
    • 141844
    • 141929
    • 142258
    • 142314
    • 143606
    • 144511
    • 145058
    • 145059
    • 150549
    • 150867
    • 150919
    • 150920
    • 151179
    • 151190
    • 151255
    • 151338
    • 151476
    • 144377
    • 150101
    • 150285
    • 150420
    • 151161
    • 151399
    • 151696
    • 144209
    • 144463
    • 150018
    • 150107
    • 150690
    • 150883
    • 141492
    • 141519
    • 141552
    • 141726
Amount recalled
27,638 units

This recall covers 20 products

The agency filed one notice per product. You are reading one of them; the other 19 are below.

7 more are in the archive.

Where it was sold

  • Nationwide

Why it was recalled

Ameditech is recalling drug abuse tests because they have shown reduced reactivity.

This product could cause temporary or reversible health problems — stop using it.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new Ameditech Inc. recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (openFDA)

Read the FDA (openFDA device enforcement) notice

Notice updated Nov 9, 2016 · Data as of Sep 19, 6:06 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.